EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Immunoediting and precision biomarkers in prostate cancer: The emerging role of liquid biopsy, immune contexture and HLA genotype (Review)

Constantin N Baxevanis, Savvas Stokidis, Sotirios P Fortis, Maria Goulielmaki, Ourania E Tsitsilonis, Angelos D Gritzapis

International Journal of Oncology · 13.07.2026 · 69 (3) · 1-23

DOI: 10.3892/ijo.2026.5917 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Oncology, online erschienen am 13.07.2026. Verfasst von Constantin N Baxevanis und 5 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Immunology and Immunotherapy Center, Department of Immunology, Saint Savas Cancer Hospital, 11522 Athens, Greece. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Biomarkers, Tumor, HLA Antigens. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 229 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsBiomarkers, TumorHLA AntigensHumansLiquid BiopsyMalePrognosisImmunoediting, CancerCirculating Tumor DNAPrecision MedicineNeoplastic Cells, CirculatingTumor Microenvironment

Stichwörter der Autor:innen

HLA genotypebiomarkerscirculating tumor DNAcirculating tumor cellsextracellular vesiclesimmunoeditingliquid biopsyprostate cancertumor immune microenvironment

Substanzen

Biomarkers, TumorHLA AntigensCirculating Tumor DNA

Autor:innen und Institutionen

  • Cancer Immunology and Immunotherapy Center, Department of Immunology, Saint Savas Cancer Hospital, 11522 Athens, Greece.
  • Flow Cytometry Unit, Department of Biology, National and Kapodistrian University of Athens, 15784 Athens, Greece.

Zitieren

APA

Baxevanis, C. N., Stokidis, S., Fortis, S. P., Goulielmaki, M., Tsitsilonis, O. E., & Gritzapis, A. D. (2026). Immunoediting and precision biomarkers in prostate cancer: The emerging role of liquid biopsy, immune contexture and HLA genotype (Review). International Journal of Oncology, 69(3), 1-23. https://doi.org/10.3892/ijo.2026.5917

Vancouver

Baxevanis CN, Stokidis S, Fortis SP, Goulielmaki M, Tsitsilonis OE, Gritzapis AD. Immunoediting and precision biomarkers in prostate cancer: The emerging role of liquid biopsy, immune contexture and HLA genotype (Review). International Journal of Oncology. 2026;69(3):1-23. doi:10.3892/ijo.2026.5917

BibTeX
@article{Baxevanis2026,
  author = {Baxevanis, Constantin N and Stokidis, Savvas and Fortis, Sotirios P and Goulielmaki, Maria and Tsitsilonis, Ourania E and Gritzapis, Angelos D},
  title = {Immunoediting and precision biomarkers in prostate cancer: The emerging role of liquid biopsy, immune contexture and HLA genotype (Review)},
  journal = {International Journal of Oncology},
  year = {2026},
  volume = {69},
  number = {3},
  pages = {1--23},
  doi = {10.3892/ijo.2026.5917}
}
Kostenlos starten →